| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/11/2002 | US20020042399 Analgesics; skin disorders |
| 04/11/2002 | US20020042397 4-hydroxycinnoline-3-carboxyamides as antiviral agents |
| 04/11/2002 | CA2425185A1 Benzimidazole and indole derivatives as crf receptor modulators |
| 04/11/2002 | CA2424222A1 Inhibitors of prenyl-protein transferase |
| 04/10/2002 | EP1194418A1 Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof |
| 04/10/2002 | EP1194417A1 Phenoxy fluoropyrimidines |
| 04/10/2002 | EP1194415A2 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for their preparation |
| 04/10/2002 | EP1194410A1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 04/10/2002 | EP1194409A1 Pyrazolidinol compounds |
| 04/10/2002 | EP1194152A1 Src kinase inhibitor compounds |
| 04/10/2002 | EP0950046B1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 04/10/2002 | EP0874842B1 Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
| 04/10/2002 | CN1344261A 2,4-diamino-1,3,5-triazines, method for producing them and their use as herbicides and plant growth regulators |
| 04/10/2002 | CN1344256A (Hetero) aryl-bicyclic heteroaryl derivatives, their prepn. and their use as protease inhibitors |
| 04/10/2002 | CN1344255A Novel cationic oxidation bases, their use for dyeing keratin fibres, dyeing compsns. and dyeing methods |
| 04/10/2002 | CN1344254A Quinoline derivatives and quinazoline derivatives |
| 04/10/2002 | CN1344160A Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 04/10/2002 | CN1082371C NK-1 receptor antagonist and 5HT3 receptor antagonists for treating emesis |
| 04/09/2002 | USRE37650 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| 04/09/2002 | US6369094 3-(n-methyl-2(r)-pyrrolidinylmethyl)-5-(2-phenylsulphonylethyl )-1h-indole, analgesic for migrane |
| 04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
| 04/09/2002 | US6369077 Protease inhibitors |
| 04/09/2002 | US6369076 Analgesics |
| 04/09/2002 | US6369069 Cardiovascular disorders |
| 04/09/2002 | US6369068 Amino substituted pyrimidine containing compounds |
| 04/09/2002 | US6369057 Quinoxalines, processes for their preparation and their use |
| 04/09/2002 | US6368814 Tricyclic antidepressants and metabolites thereof |
| 04/09/2002 | CA2229000C 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
| 04/09/2002 | CA2215732C Quinazoline derivatives |
| 04/09/2002 | CA2024185C Substituted 4,5-diamino-1,2,4-triazol-3-(thi)ones |
| 04/04/2002 | WO2002026891A1 Modified carbocyanine dyes and their conjugates |
| 04/04/2002 | WO2002026734A1 PIPERAZIN-2-ONE AMIDES AS INHIBITORS OF FACTOR Xa |
| 04/04/2002 | WO2002026720A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa |
| 04/04/2002 | WO2002026706A2 17-beta-hydroxysteroid dehydrogenase-ii inhibitors |
| 04/04/2002 | WO2002026696A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 04/04/2002 | WO2002026228A1 Benzimidazolone antiviral agents |
| 04/04/2002 | WO2001090079A3 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists |
| 04/04/2002 | WO2001074815A3 Phenyl-substituted imidazopyridines |
| 04/04/2002 | WO2001074810A3 Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists |
| 04/04/2002 | WO2001074773A3 Phenyl-substituted indoles as histamine h3-receptor antagonists |
| 04/04/2002 | US20020040150 Skin treatment compositons containing a cationic polymer and a microparticle or nanoparticle vector |
| 04/04/2002 | US20020040149 EP4 receptor selective agonists in the treatment of osteoporosis |
| 04/04/2002 | US20020040147 Novel catechols as antimicrobial agents |
| 04/04/2002 | US20020040146 Useful as inhibitors of metalloproteases, e.g. zinc proteases, and which are effective in therapy of disease states associated with vasoconstriction |
| 04/04/2002 | US20020040048 (2S,4R)-4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid N'-isobutyl-N'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 04/04/2002 | US20020040025 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 04/04/2002 | US20020039774 Anticholesterol agents |
| 04/04/2002 | CA2422873A1 Piperazin-2-one amides as inhibitors of factor xa |
| 04/03/2002 | EP1193265A2 A process for the preparation of 4-[2-(aryl or heterocyclo)-1H-imidazol-1-yl]benzenesulfonamides |
| 04/03/2002 | EP1193252A2 Beta-Lactams useful for preparation of substituted isoserine esters using metal alkoxides |
| 04/03/2002 | EP1192951A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 04/03/2002 | EP1192150A1 New pharmaceutically active compounds |
| 04/03/2002 | EP1192148A1 Thiochroman derivatives resisting neurological disorders |
| 04/03/2002 | EP1192135A2 Serine protease inhibitors |
| 04/03/2002 | EP1192132A2 Serine protease inhibitors |
| 04/03/2002 | EP1192131A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives |
| 04/03/2002 | EP1191931A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 04/03/2002 | CN1343217A New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 04/03/2002 | CN1343201A Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them |
| 04/02/2002 | US6365652 Trisaryl-1,3,5-triazine ultraviolet light absorbers |
| 04/02/2002 | US6365603 Aromatic compounds and pharmaceutical compositions containing them |
| 04/02/2002 | US6365584 For prophylaxis and therapy of inflammatory and/or allergic diseases, lung fibrosis, fibrosing alveolitis and scarring, collagenoses such as lupus erythematodes and sclerodermia as well as arteriosclerosis, psoriasis and neoplasm |
| 04/02/2002 | US6365552 Substituted 3-phenylpyrazoles |
| 04/02/2002 | US6365335 Sensitivity and decreased in residual color |
| 04/02/2002 | CA2097928C Uracil derivatives |
| 03/28/2002 | WO2002024815A1 Cyanine dyes |
| 03/28/2002 | WO2002024690A2 Efficient process for the preparation of a factor xa inhibitor |
| 03/28/2002 | WO2002024685A1 Indole derivatives and their use as antifungal and/or antiparasitic agents |
| 03/28/2002 | WO2002024683A1 Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 03/28/2002 | WO2002024682A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 03/28/2002 | WO2002024667A1 4-amino-quinazolines |
| 03/28/2002 | WO2002024665A1 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 03/28/2002 | WO2002024662A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 03/28/2002 | WO2002024661A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 03/28/2002 | WO2002024658A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 03/28/2002 | WO2002024655A1 Isoquinolinone potassium channel inhibitors |
| 03/28/2002 | WO2001077075A3 Inhibitors of inflammation and reperfusion injury |
| 03/28/2002 | WO2001023377A9 Polymorphic salt |
| 03/28/2002 | US20020038035 1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
| 03/28/2002 | US20020037912 Factor viia inhibitors |
| 03/28/2002 | US20020037907 Substituted 2- (S) -hydroxy-3- (piperidin-4-yl-methylamino) -propyl ethers and substituted 2-aryl-2- (R) - hydroxy-1- (piperidin-4-yl-methyl) -ethylamine beta-3 adrenergic receptor agonists |
| 03/28/2002 | US20020037889 Imidazolidin-2-one derivatives; inhibiting bone resorption, vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, arthritis, viral disease, cancer and metastatic tumor growth |
| 03/28/2002 | US20020037888 4-imidazol-1-ylmethyl-2-(2-(2-oxo-piperidin-1-yl)-phenoxy) -benzonitrile for example; farnesyl-protein transferase inhibitors; treating cancer, benign proliferative disorder, hepatitis virus, restenosis, and polycystic kidney disease |
| 03/28/2002 | US20020037878 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/28/2002 | US20020037856 Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 03/28/2002 | US20020037534 Combinatorial preparation of a substance library with removal of a zwitterionic compound by precipitation |
| 03/28/2002 | DE10042447A1 Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports Protein from the intestines of vertebrates, which absorbs cholesterol, as well as use of this protein for the identification of inhibitors of intestinal cholesterol transport |
| 03/28/2002 | CA2424576A1 Efficient process for the preparation of a factor xa inhibitor |
| 03/28/2002 | CA2423151A1 Indole derivatives and their use as antifungal and/or antiparasitic agents |
| 03/28/2002 | CA2422488A1 4-amino-quinazolines |
| 03/28/2002 | CA2421823A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 03/27/2002 | EP1191026A1 New pyridazine endothelin antagonists |
| 03/27/2002 | EP1189893A2 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)one |
| 03/27/2002 | EP1189889A1 Compositions and methods for inhibiting cell death |
| 03/27/2002 | EP1189883A2 Substituted pyrrolidines as cell adhesion inhibitors |
| 03/27/2002 | EP1189692A1 Novel triazine-based detoxification agents and their use |
| 03/27/2002 | EP1189640A1 Pharmaceutical complex |
| 03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
| 03/27/2002 | EP1189609A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics |
| 03/27/2002 | EP0840607B1 Novel medical use |